ϳԹ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • ϳԹ News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jul 29 2019

Full Issue

House Democrats May Have Had Busy Year, But There's Little Progress To Show Their Constituents

House Democrats have passed legislation on gun control, immigration and health care, yet the measures die in the Senate. As they head home to face constituents during recess, it's unclear if that message will translate. "I go home and people say, ‘How come your party isn’t helping me with the cost of inhalers or EpiPens, or health care in general?’" said Rep. Elissa Slotkin, Democrat of Michigan. In other news from Capitol Hill: surprise medical bill votes, mental health clinics and cannabis products.

At critical moments, disconnects between liberals and moderates on both policy and style have exploded into public view, and Mr. Trump has diverted attention from key Democratic victories at almost every turn. A vote on a meticulously negotiated agreement among Democrats on legislation to raise the minimum wage was overshadowed this month after Mr. Trump made an incendiary attack on four freshman congresswomen of color; House Democrats spent the first half of their week debating and passing a resolution to condemn his comments as racist. “He knows exactly how to distract us, and we take the bait — we take the bait every time,” said Representative Elissa Slotkin, Democrat of Michigan, another first-term lawmaker from a Trump district. “And then I go home and people say, ‘How come your party isn’t helping me with the cost of inhalers or EpiPens, or health care in general?’ And we do care about those things; it’s just not what makes sexy headlines.” (Hirschfeld Davis, 7/28)

Two lawmakers have banded together to whip members of a U.S. House of Representatives health panel to vote on an alternative policy to ban "surprise" medical bills. The effort by Reps. Donna Shalala (D-Fla.) and Phil Roe (R-Tenn.) within the House Committee on Education and Labor focuses on a bill more generous to physicians and hospitals than legislation already approved by the House Energy and Commerce Committee. The move could further tangle the already contentious debate over how the feds should end the practice of balance billing. The issue of "surprise" medical bills is often instigated by specialty physician groups that contract with hospitals without joining their insurance networks. (Luthi, 7/26)

The Senate on Thursday passed a two-month extension of a Medicaid demonstration enabling innovative mental health centers in eight states to offer broad, coordinated services for serious mental illness and substance use disorders. Advocates hope the House will approve the temporary funding measure next week as a routine, consent calendar item. The Senate bill, sponsored by Sen. Roy Blunt (R-Mo.), would provide about $60 million to the program through Sept. 13. It previously was delayed by holds by Republican senators. Two-year funding for the $1 billion certified community behavioral health clinic (CCBHC) ended on July 14. (Meyer, 7/26)

States have led the way in pushing Congress to lighten up about marijuana and other products that come from the cannabis plant. That’s because they see the potential for new industries benefiting their residents, and new tax revenue. But now that Congress is helping, it turns out the states will need a lot of help from Washington regulators to make sure the products don’t hurt people.Earlier this month, attorneys general from 33 states filed comments with the Food and Drug Administration letting the agency know just how much they would need its help now that Congress has authorized the sale of some cannabis-related products (though not marijuana). (Zeller, 7/29)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • ϳԹ
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF